BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help
Documents 1-25 out of over 518 found
  Current Search:  carboplatin: 2041  
100%
HTML
Partnering opportunities with Antigenics
Home - About Antigenics - Partners Partnering opportunities Antigenics seeks to establish corporate partnerships with leading pharmaceutical companies with strengths that complement and enhance our own.
Oncophage can potentially be used to treat all cancer types, and can be administered as a monotherapy or in combination with surgery, radiation, chemotherapies or other...
Matching: carboplatin Find similar documents More document info
100%
HTML
Aroplatin liposomal platinum agent
Home - Products & Technologies - Cancer Products Aroplatin™ liposomal platinum agent An investigational product What is Aroplatin?
It is a new chemical entity that is structurally similar to Eloxatin ® (oxaliplatin, Sanofi-Aventis ), an approved treatment for colorectal cancer.
Although platinum-based therapies (such as carboplatin and cisplatin ) exhibit...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: carboplatin Find similar documents More document info
100%
HTML
Allos Therapeutics
Home.
Site Map.
Search - --- » » »-- Clinical Trials | Trials Open for Enrollment | RT-014 Title of Study: A Phase 1 Open-Label Study of efaproxiral and Supplemental Oxygen with Concurrent Paclitaxel, Carboplatin, and Thoracic Radiation Therapy in Patients with Locally Advanced, Unresectable (Stage IIIA/IIIB) Non-small Cell Lung Cancer Objectives: •...
Matching: Find similar documents More document info
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.